Literature DB >> 12109855

MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma.

Xavier Leroy1, Farid Zerimech, Laurent Zini, Marie-Christine Copin, Marie-Pierre Buisine, Bernard Gosselin, Jean-Pierre Aubert, Nicole Porchet.   

Abstract

We studied, by immunohistochemical analysis, the expression of MUC1 and epithelial membrane antigen in 44 stage pT1 renal cell carcinomas (RCCs). Six patients had a metastatic evolution. The percentage of stained cells was determined for each tumor. All tumors and normal adjacent renal parenchyma were stained. In normal kidney, distal convoluted tubules and collecting ducts stained strongly with an apical distribution. In tumors, there was a significant statistical correlation of the MUC1 expression level with the nuclear grade and with tumor progression. High-grade tumors had more stained cells than did low-grade tumors. Metastatic tumors also were more stained than nonmetastatic lesions. By using the Kaplan-Meier method and the log-rank test, we observed that patients with fewer than 10% of stained cells had no metastatic evolution. In contrast, patients with 70% or more stained cells had significantly lower metastasis-free survival rates. We conclude that MUC1 is expressed in RCC and is associated with tumor progression in pT1 RCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12109855     DOI: 10.1309/1F99-BPDY-7DHH-9G97

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Tetsuro Tomonaga; Hakushi Kim; Kazuya Hanai; Yukio Usui; Yoshihiro Nagata; Masaki Miyazawa; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toyoaki Uchida; Toshiro Terachi; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2013-01-01       Impact factor: 5.150

Review 2.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

3.  Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model.

Authors:  Julia Pinkhasov; M Lucrecia Alvarez; Latha B Pathangey; Teresa L Tinder; Hugh S Mason; Amanda M Walmsley; Sandra J Gendler; Pinku Mukherjee
Journal:  Cancer Immunol Immunother       Date:  2010-09-08       Impact factor: 6.968

4.  Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.

Authors:  Małgorzata Borzym-Kluczyk; Iwona Radziejewska; Marzanna Cechowska-Pasko
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

Review 5.  Host response in tumor diagnosis and prognosis: importance of immunologists and pathologists alliance.

Authors:  Olivera J Finn
Journal:  Exp Mol Pathol       Date:  2012-10-23       Impact factor: 3.362

6.  Differential expression and clinical relevance of MUC1 in renal cell carcinoma metastasis.

Authors:  Steffen Rausch; Johanna Beermann; Marcus Scharpf; Jörg Hennenlotter; Falko Fend; Arnulf Stenzl; Daniel Schollenberger; Jens Bedke; Stephan Kruck
Journal:  World J Urol       Date:  2016-03-19       Impact factor: 4.226

7.  Effects of resveratrol on gene expression in renal cell carcinoma.

Authors:  Ting Shi; Louis S Liou; Provash Sadhukhan; Zhong-Hui Duan; Andrew C Novick; John G Hissong; Alexandru Almasan; Joseph A DiDonato
Journal:  Cancer Biol Ther       Date:  2004-09-21       Impact factor: 4.742

8.  Mucin-1 Increases Renal TRPV5 Activity In Vitro, and Urinary Level Associates with Calcium Nephrolithiasis in Patients.

Authors:  Mingzhu Nie; Manjot S Bal; Zhufeng Yang; Jie Liu; Carolina Rivera; Andrea Wenzel; Bodo B Beck; Khashayar Sakhaee; Denise K Marciano; Matthias T F Wolf
Journal:  J Am Soc Nephrol       Date:  2016-04-01       Impact factor: 10.121

9.  Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

Authors:  Karl X Knaup; Thomas Hackenbeck; Bernt Popp; Johanna Stoeckert; Andrea Wenzel; Maike Büttner-Herold; Frederick Pfister; Markus Schueler; Didem Seven; Annette M May; Jan Halbritter; Hermann-Josef Gröne; André Reis; Bodo B Beck; Kerstin Amann; Arif B Ekici; Michael S Wiesener
Journal:  J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 10.121

Review 10.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.